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ABSTRACT The methyl-accepting chemotaxis proteins (MCPs)
of Escherichia coli undergo reversible methylation that has been
correlated with adaptation of cells to environmental stimuli. MCPI,
the product of the tsr gene, accepts methyl groups at multiple sites
that are located on two tryptic peptides, denoted KI and RI. A
second modification of the MCPs, which is not methylation, has
been designated the CheB-dependent modification. A CheB-de-
pendent modification occurs on methyl-accepting peptide KI and
allows additional methyl groups to be incorporated into this pep-
tide. We have performed partial amino acid sequence analyses on
radiolabeled peptides Ki and RI derived from MCPI and have
identified several methyl-accepting sites. We found that, in the
absence of CheB-dependent modification, a site in peptide Ki is
unable to accept methyl groups. Correlation of this protein se-
quence data with the nucleotide sequence of the tsr gene [Boyd,
A., Kendall, K. & Simon, M. I. (1983) Nature (London) 301, 623-
626] suggests that CheB-dependent modification of MCPI is the
enzymatic deamidation of glutamine to methyl-accepting glutamic
acid. Possible roles for this deamidation in bacterial chemotaxis
are discussed.
Escherichia coli swim in a random walk resulting from alter-
nating clockwise (tumbling behavior) and counterclockwise
(straight swimming behavior) flagellar rotation. The bacteria
respond to changes in their environment by modulating the
probabilities of clockwise and counterclockwise rotations. Cells
suppress their tumbling in response to attractants and increase
their tumbling in the presence of repellents. Subsequently, the
cells undergo a process of adaptation, which entails a return to
their prestimulus swimming pattern (1-3).
These behavioral responses of E. coli to certain stimuli are
mediated by a family of transmembrane proteins, the methyl-
accepting chemotaxis proteins (MCPs) (4). At least three dif-
ferent MCPs are essential in the sensory transduction process.
MCPI, MCPII, and MCPIII, encoded by the tsr, tar, and trg
genes, respectively, mediate cellular responses to different
subsets of attractants and repellents (5-8). A fourth gene, tap,
seems to encode an additional MCP whose functional role in
chemotaxis has not yet been defined (9-11). The behavioral re-
sponse is initiated by interaction of the effector molecule or an
effector-receptor complex in the periplasm with the appropri-
ate MCP (12-16).
MCPs undergo reversible methylations in the cell cyto-
plasm, and changes in the level of methylation correlate with
the adaptation of cells to environmental stimuli (6, 17-19).
Methylation is mediated by a protein methyltransferase en-
coded by the cheR gene and results in the formation of the y-
methyl ester of glutamic acid (20-23). A protein methylesterase
encoded by the cheB gene balances the methyltransferase ac-
tivity by removing methyl groups (24, 25). Each MCP has mul-
tiple sites at which methylation and demethylation may occur
(26-29). For example, MCPI may accept a maximum of six
methyl groups, and MCPII accepts at least four methyl groups
(30, 31).
A second covalent modification of the MCPs also occurs at
multiple sites and is dependent on the presence of the cheB
gene (32, 33). The chemical nature of the modification, de-
noted the CheB-dependent modification, had not been iden-
tified previously, and its specific role in chemotaxis is unclear.
However, several properties suggest that CheB-dependent
modification may be the enzymatic conversion of glutamine to
glutamic acid residues (32). Each CheB modification of MCPs
results in the addition of one net negative charge to the protein
and allows additional methyl groups to be accepted by the MCP
(31, 32).
We have previously shown (30) that two tryptic peptides ac-
cept methyl groups in MCPI and MCPII. One of these, des-
ignated peptide K1, contains lysine and methionine; the other,
designated peptide RI, contains arginine. In addition, peptide
K1 derived from MCPI contains at least one CheB-modifiable
site. To identify the CheB-modifiable amino acid(s) and elu-
cidate the chemical nature of the CheB-dependent modifica-
tion, we have performed protein sequence determinations on
the radiolabeled K1 and RI peptides derived from MCPI. One
of the methylated positions observed in peptide K1 that is
methylated in protein obtained from a wild-type background
remains completely unmethylated in protein synthesized in a
cheB mutant. In conjunction with the amino acid sequence of
MCPI deduced from the nucleotide sequence of the tsr gene
(34), these data provide compelling evidence that CheB mod-
ification is the enzymatic deamidation of glutamine to glutamic
acid. Possible functions for this deamidation in chemotaxis are
discussed.
MATERIALS AND METHODS
Strains. E. coli strains and A-E. coli hybrid phage were as
described (30, 31). All strains and phages were the generous
gifts of J. S. Parkinson and M. Simon.
Radiolabeling of MCPs, Electrophoresis, Enzyme Diges-
tions, HPLC Analysis, and Isolation of Peptides. These pro-
cedures were exactly as described (30, 31). Neutralized HPLC
fractions containing radiolabeled peptides K1 and Ri were pooled
and lyophilized directly without removal of sodium phosphate.
Abbreviation: MCP, methyl-accepting chemotaxis protein.
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Radiolabeled Sequence Analysis. The sequences shown in
Fig. 1 were determined on a spinning cup sequenator with a
single cleavage program as described (35, 36). To minimize hy-
drolrsis of the methyl esters during sequence determinations
on [ H]methyl-labeled peptides, the sequenator was modified
to bypass the conversion flask; the anilinothiazolinone deriv-
atives were extracted from the cup with 1-chlorobutane/0. 1%
dithiothreitol and collected. For each sequenator cycle, the
fraction that contained the derivatized amino acid was dried
under argon and dissolved in 0.2 ml of acetonitrile. Radioac-
tivity in the entire fraction was determined by liquid scintil-
lation counting. All samples were loaded in 0.15% NaDodSO4
(Bio-Rad, twice recrystallized), extracted with 4 ml of 1-chlo-
robutane/0. 1% dithiothreitol, and double coupled with an ex-
tended first cleavage time. Sequence analysis of [3S]methio-
nine-labeled peptide K1 was performed in duplicate and yielded
similar results both times.
The sequences shown in Fig. 2 were determined on a gas-
phase sequenator as described (37). Samples were loaded with
0.3 mg of sperm whale myoglobin in 1% NaDodSO4. To min-
imize hydrolysis of the methyl esters, delivery of the 1 M HCl/
methanol was turned off, and after delivery of 1-chlorobutane
the extracted anilinothiazolinone derivatives (=0.3 ml) were
collected. No wash was performed, and recovery was estimated
to be 80%. For each sequenator cycle, the sample was trans-
ferred to a scintillation vial and 4 ml of Liquifluor (New En-
gland Nuclear) was added for determination of radioactivity by
scintillation counting (50 min per vial). Sequenator lag, which
is observed as a significant yield (> 10%) of the amino acid from
one cycle in the following cycle, resulted from the large quan-
tity of sodium phosphate (pH 2.2) in the samples, which changed
the pH of the coupling buffer.
Several [3H]methyl-labeled peptides were incubated for var-
ious times under the conditions used for coupling in the se-
quenator (pH 9.0 at 54°C). These base-catalyzed hydrolyses in-
dicated that the half-life of the methyl esters averaged 7 hr. The
coupling time for each sequenator cycle was a total of 30 min
in the spinning cup sequenator and 15 min in the gas-phase se-
quenator. Thus, it would be possible to carry out at least 12
sequenator cycles on the [3H]methyl-labeled peptide samples
before the radioactivity was lost due to nonspecific hydrolysis.
As can be seen in the data of Figs. 1 and 2, assignment of meth-
ylated residues beyond cycle 16 is tentative.
Amino Acid Analyses. Pronase digestion of radiolabeled
peptides K1 and RI was performed in 0.2 M N-ethylmorpho-
line acetate (pH 7.0) at 34°C. Two micrograms of Pronase (10
mg/ml in 0.2 M N-ethylmorpholine acetate, pH 7.5) was added
four times over the course of 8 hr. Samples were lyophilized,
and the amino acids were dissolved in 20-30 ,ul of 0.4 M so-
dium borate (pH 9.5), derivatized with o-phthalaldehyde, and
separated by reverse-phase HPLC as described (38, 39). Frac-
tions (0.5 min) were collected into scintillation vials from the
time of injection, and radioactivity was determined. Elution
positions of 19 amino acids (except proline) in addition to glu-
tamic acid y-methyl ester and aspartic acid P-methyl ester were
determined with known amino acid standards and were repro-
ducible (39). Elution times of derivatized tyrosine, methyl as-
partate, methyl glutamate, and methionine were 39, 39.5, 43,
and 48 min, respectively.
Preliminary Pronase treatment of [3S]methionine-labeled
tryptic peptides derived from MCPIII showed that >85% of
the radiolabel recovered was free methionine. The remainder
eluted as several peaks that did not correspond to any of the
standard amino acids and probably represented incompletely
cleaved small peptides.
RESULTS
Positions of Methyl-Accepting Sites in Tryptic Peptides from
MCPI. Methyl-accepting sites on the two methyl-accepting
tryptic peptides from MCPI, K1 and R1, have been extensively
characterized with respect to their identity and number (30).
The methylated forms of peptides K1 and R1 have been des-
ignated T1-T6 in order of elution from a reverse-phase HPLC
column. Methylated peptide T4 corresponds to the dimethylat-
ed form of peptide R1. Peptides T2, T3, T5, and T6 represent
the mono-, di-, tri-, and tetramethylated forms of CheB-mod-
ified peptide KI, respectively, and are not observed in MCPI
produced in a cheB mutant background (30, 31). Peptide Ti is
the monomethylated form of peptide K1 that does not contain
a CheB modification; peptide Ti is only observed as a major
methylated form in MCPI produced in cheB cells and does not
accept more than one methyl group (31).
To localize the positions of the methyl-accepting sites in the
amino acid sequences of the peptides, radiolabeled peptides
were isolated from MCPI synthesized in wild-type cells and
subjected to protein sequence determinations. Sequence anal-
ysis was performed on [3H]methyl-labeled peptide K1 that was
CheB-modified (peptides T3 and T5 combined) and established
methylated residues at positions 3, 10, and perhaps 17 (Figs.
1 and 2). A methylated residue also was found at position 11 in
the second methyl-accepting peptide, R1, from MCPI. Deter-
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FIG. 1. Radiolabeled protein sequence analysis of methyl-accept-
ing tryptic peptides from MCPI. (Top) Sequenator run on [35S]methi-
onine-labeledpeptide K1 isolated from MCPI synthesized in cheRB-de-
leted cells (RP2859 Aind- infected with Afla9l). (Middle) Sequenator
run on [3H]methyl-labeled peptides T3 andT5 (K1) isolated from MCPI
produced in tar cells (MS5235). Equal amounts of radioactivity were
present in the T3 and T5 peptides (4,000 3H cpm each) used in the anal-
ysis. (Bottom) Sequence determination on [3H]methyl-labeled peptide
T4 (R1) isolated as for peptides T3 and T5 (a'8,000 3H cpm).
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FIG. 2. Sequence results on peptides Ki and Ri summarized. The
carboxyl-terminal lysine and arginine residues were determined by
incorporation of these 3H-labeled amino acids into the peptides (30).
mination of more than 16 or 17 residues of sequence on the
[3H]methyl-labeled peptides was not possible due to the lability
of the methyl esters under the conditions used in the sequen-
ator coupling step. Similar analyses of [3S]methionine-labeled
peptide KL indicated that residue 15 contained methionine.
The identities of the methylated amino acids in peptides K1
and RI were confirmed as methylglutamyl residues by amino
acid analysis. A mixture of [3H]methyl-labeled peptides T3 and
T4 (in a 1:1 ratio as judged by 3H incorporation) was digested
with Pronase. Quantitation of free amino acids after derivati-
zation with o-phthalaldehyde (38, 39) showed that 25% of the
recovered radiolabel comigrated with glutamic acid y-methyl
ester. Approximately 60% of the radiolabel was found in the
flow-through peak of the analysis and most likely represented
[3H]methanol released during the o-phthalaldehyde derivati-
zation at pH 9.5. No radioactivity was associated with methyl
aspartate in this amino acid digest of [3H]methyl-labeled KI
and Ri peptides (data not shown). The remainder of the ra-
diolabel eluted in four peaks that did not correspond to any of
the standard amino acids and may be incompletely cleaved small
peptides (data not shown). We conclude that MCPI synthesized
in a wild-type background accepts methyl groups on gluta-
mate residues at the positions in peptides K1 and Ri indicated
in Fig. 2.
Unmodified Peptide KI Lacks a Methyl-Accepting Site. We
compared the methylated positions in CheB-modified and un-
modified peptide KI directly by subjecting [3H]methyl-labeled
peptides Ti and T2 to protein sequence analyses. Each peptide
contained one methyl ester, but peptide T1 did not contain a
CheB modification. Sequence determination on CheB-modi-
fied peptide T2 showed the presence of methyl esters at po-
sition 3 (Fig. 3). Position 10 may also be methylated, suggesting
that, as isolated by HPLC from a population of MCPI mole-
cules, peptide T2 may consist of a mixture of monomethylated
isomers, each of which is methylated at one of the possible
methyl-accepting glutamate residues.
In contrast, sequence analysis of the unmodified [3H]methyl-
labeled peptide T1 showed the absence of methyl esters at po-
sition 3 (Fig. 3). The data suggest that this peptide contained
a methylated residue at position 10, although the peak is broad.
This is most likely due to "sequenator lag" which results from
incomplete coupling at any or all of the preceding sequenator
cycles. In the analyses shown in Fig. 3, the peptide T1 sample
contained twice as much radioactivity as the peptide T2 sample.
We therefore believe that the absence of a methyl ester at po-
sition 3 in peptide Ti reflects the inability of this residue to
accept methyl groups in the absence of CheB-dependent mod-
ification. Due to hydrolysis of the methyl esters during se-
quence analysis, the presence or absence of methyl esters can-
not be confirmed at position 17 in the two sequences (Fig. 3).
DISCUSSION
MCPI is multiply methylated in wild-type E. coli cells, and the
methyl esters are found on two tryptic peptides, K1 and RI (30).
We have established positions of methylated glutamic acid res-
idues and a methionine residue in methyl-accepting peptides
derived from MCPI produced in wild-type cells and have cor-
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FIG. 3. Methyl-accepting sites in CheB-modified and unmodified
peptide Ki from MCPI. (Upper) Radioactivity in cycles of a sequenator
run on [3H]methyl-labeled peptide T2 isolated from MCPI produced in
tar cells (MS5235). This peptide was CheB-modified and contained
33,000 3H cpm. wt, Wild type. (Lower) Sequence determination on
[3H]methyl-labeled peptide Ti (-6,000 3H cpm) isolated from MCPI
produced in a cheB background (RP4209). A, Background radioactivity
in a blank cycle prior to sample loading.
related this information with the nucleotide sequence of the tsr
gene recently determined by Boyd et al. (34). Only one se-
quence in the single open reading frame of the tsr gene con-
tained a methionine residue 15 amino acids from a tryptic cleav-
age site. This amino acid sequence derived from the nucleotide
sequence of tsr is shown in Fig. 4 and has several features that
unambiguously identify it as methyl-accepting peptide K1. The
peptide is 23 amino acids long and ends in lysine, in agreement
with its chromatographic properties on HPLC and the incor-
poration of [3H]lysine (30).
The predicted sequence contains glutamic acid at position 10
and glutamine at positions 3 and 17 (Fig. 4; see below). These
positions are observed as methylated sites in peptide K1. The
I to 20
Kl DNA TEQQAASLEETAASMEQLTATVKProtein - -E - - - - M-(E)- - - K
~~~~1020
R1 DNA VTQQNAALVEESAAAAAALEEQASR
Protein - - - - - - - - E - - - - - - .R....R
Me
FIG. 4. Amino acid sequences of methyl-accepting peptides de-
duced from the nucleotide sequence of tsr (34). Amino acid sequences
corresponding to the radiolabeled protein sequence determinations in
Fig. 1 are shown. Dashes indicate the absence of a radiolabeled residue
at that position (see Fig. 2). The single-letter code for amino acids is
given in Dayhoff (40); Q and E denote glutamine and glutamic acid,
respectively.
Methyl peptide T2 (Kl)
Iwt
IM
Methyl peptide Tl (Kl)
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glutamine positions are compatible with our suggestion that the
CheB modification may be the conversion of glutamine to glu-
tamic acid. This does not exclude other sites (residues 4, 9, and
16) as possible methyl-accepting sites. The extensive homology
in this region of the tsr and tar genes (41) supports the idea that
this sequence contains sites for methyltransferase activity.
The nucleotide sequence of tsr predicts that position 3 is a
glutamine (Fig. 4). The identification of positions of methyl-
ated residues shows that residue 3 in peptide K1 derived from
MCPI synthesized in wild-type cells is a methyl-accepting glu-
tamic acid (Fig. 2). However, the same residue in the unmod-
ified peptide from MCPI produced in cheB mutants is not
methylated. We conclude that the CheB modification of pep-
tide K1 may be the enzymatic conversion of the glutamine at
position 3 to methyl-accepting glutamic acid. The CheB-mod-
ified and unmodified forms of peptide K1 both accept methyl
groups at position 10, which is encoded as glutamic acid in the
tsr gene. At this position the methyl-accepting glutamic acid is
adjacent to another glutamic acid at position 9 and may account
for methylation of the unmodified form. This is consistent with
the idea that pairs of glutamic acid residues create a methyl-
accepting site recognized by the methyltransferase (34). At po-
sition 3, the CheB modification of glutamine to glutamic acid
thus results in the formation of a pair of glutamic acid residues
(positions 2 and 3), of which position 3 is a methyl-accepting
site.
All other properties of the CheB-dependent modification are
consistent with its being a deamidation process. Each CheB
modification results in the addition of one net negative charge
to MCPs (31, 32). pH-dependent changes in the chromato-
graphic elution position of the modifiable peptide suggest that
the CheB-modified group has a pKa similar to that of glutamic
acid (42). CheB modification is irreversible and is stable to base-
catalyzed demethylation conditions (31, 32). The modification
allows additional methyl groups to be incorporated into methyl-
accepting peptide K1 (31). Because the data are so extensive,
we suggest the use of "deamidation" or "CheB-dependent
deamidation" rather than the term "modification" for this pro-
cess.
The sequences shown in Fig. 4 also suggest that the deam-
idation might occur at a second site in peptide K1 (residue 17)
to produce a third methyl-accepting glutamic acid. We previ-
ously determined that peptide K1 is subject to only one deam-
idation yet it may accept two or three additional methyl groups
subsequent to this single deamidation (31). Because the data
regarding residue 17 in peptides T1 and T2 are ambiguous (Fig.
3) we can only propose explanations for the apparent discrep-
ancy. First, either residue 3 or residue 17 may be CheB mod-
ifiable but, when one site has been modified, the second site
is no longer reactive. This would be consistent with the possible
methyl-accepting residue at position 17 (Fig. 2). Second, MCPI
could acquire two CheB-dependent deamidations on peptide
K1 (residues 3 and 17) only in the presence of CheR, the meth-
yltransferase. We quantitate the number of deamidations on
MCPs produced in cells that are cheR (31-33); therefore, this
possibility cannot be excluded. Interestingly, the analogous
peptide from MCPIII synthesized in cheR cells is subject to two
deamidations, suggesting that this limitation or control may no
longer hold in minicells (42). Finally, it is possible that methyl
groups (up to three or four total) may be placed with a lower
frequency on other glutamate residues in peptide K1 in ad-
dition to those at positions 3, 10, and 17. Due to the high back-
ground that results from hydrolysis of the methyl esters during
sequence analysis, these lower-preference methyl-accepting sites
would not have been detected in our determinations.
Sequence comparisons within the deduced amino acid se-
quence of MCPI identified a second sequence approximately
200 amino acids carboxyl-terminal to peptide K1 that is ho-
mologous to peptide K1 (34). The homologous amino acid se-
quence (shown in Fig. 4) seems to correspond to peptide Ri.
The peptide is 25 amino acids long, ends in arginine, contains
no methionine, and contains potential methyl-accepting glu-
tamic acid residues at positions 11 and 21 (Fig. 2). The pre-
dicted sequence of peptide Ri also is conserved in the tsr and
tar gene sequences (41). In addition, the amino acid sequences
of peptide RI deduced from the tsr and tar nucleotide se-
quences (41) are in accordance with the number of methyl-ac-
cepting sites in peptides RI derived from MCPI and MCPII.
Peptide Ri from MCPI accepts two methyl groups (30), whereas
peptide Ri derived from MCPII only accepts one methyl group
(31). Comparison of the deduced amino acid sequences of pep-
tide Ri from MCPI and from MCPII reveals the substitution
of a glutamine in MCPII for the glutamic acid at residue 10 in
MCPI (39). Because the only other amino acid difference is a
serine for the alanine at residue 7, it is likely that the single
glutamic acid at position 11 in MCPII is unable to serve as a
methyl-accepting site. Two pairs of glutamic acid residues that
could serve as such recognition sites for methyltransferase are
present in the predicted sequence of peptide Ri from MCPI
but only one site is found in the predicted sequence of peptide
Ri from MCPII (41).
There are several roles for the CheB-dependent deamidation
in chemotaxis. First, it is possible that the deamidation may
have a structural function. All of the MCPs acquire multiple
deamidations (10, 32, 33, 42, 43). MCPs synthesized in wild-
type cells are maximally deamidated (31), which implies that
CheB-dependent deamidation occurs shortly after synthesis of
MCPs. Perhaps the neutral glutamine residues are required for
proper membrane insertion or assembly of newly synthesized
MCPs. Additionally, a more neutral environment in this region
of the MCP molecule may enhance CheB-MCP associations
required for proper formation of an active transducer complex.
In this regard, an in vitro methylation system constructed from
cytoplasm and membranes has not been formed in a functional
state when cheR or cheB membranes are combined with wild-
type cytoplasmic extracts (44). This suggests that the compo-
nents (MCP, CheR, CheB) may be assembled during synthesis,
and CheB-dependent deamidation may facilitate the association
process.
Second, the deamidation activity of the cheB gene product
may originally have functioned as a primitive adaptation mech-
anism prior to the existence of methylation. Recent work by
Parkinson et al. (10) and Stock et al. (45) on methylation-defi-
cient chemotactic pseudorevertants of cheR mutants supports
the idea that a methylation-independent, CheB-dependent ad-
aptation process is sufficient to allow rudimentary MCP-me-
diated chemotaxis. In the absence of methylation the irrevers-
ible nature of the deamidation process would require that MCPs
turn over and be continually resynthesized. A role for the
deamidation in adaptation thus is indicated by the idea that the
useful life-time of the MCP was maximized by providing multi-
ple sites for CheB-dependent deamidation on each MCP.
That the CheB-dependent deamidation still plays a primary
role in bacterial responses is suggested by the drastic effect of
cheB mutations on the methylation-independent chemotaxis to
oxygen and certain sugars (46, 47). We envision the existence
of additional, as yet unidentified, sensory transducer proteins
that mediate other types of taxis and that are deamidated by
CheB.
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